Protonolysis of (diimine)PtMe2 (1) complexes in CD2Cl2 containing CD3CN at -78 degrees C yields (diimine)PtMe2(H)(NCCD3)+ (4), (diimine)PtMe(NCCD3)+ (5), and methane. The relative yields of 5 and methane decrease with increasing concentrations of CD3CN. This is consistent with protonation of 1 occurring directly at the metal, rather than at a methyl group. The principle of microscopic reversibility then implies that the deprotonation in "Shilov-type C-H activation" occurs from a Pt(IV) hydridomethyl intermediate, rather than from a Pt sigma-methane complex.
Protonation of (N-N)PtPh(2) (1; N-N = diimine ArN=CMe-CMe=NAr with Ar = 2,6-Me(2)C(6)H(3) (a), 2,4,6-Me(3)C(6)H(2) (b), 4-Br-2,6-Me(2)C(6)H(2) (c), 3,5-Me(2)C(6)H(3) (d), and 4-CF(3)C(6)H(4) (e)) in the presence of MeCN at ambient temperature generates (N-N)Pt(Ph)(NCMe)(+) (2). At -78 degrees C, protonation of 1a yielded (N-N)PtPh(2)(H)(NCMe)(+) (3a), which produced benzene and 2a at ca. -40 degrees C. Protonation of 1a-e in CD(2)Cl(2)/Et(2)O-d(10) furnished (N-N)Pt(C(6)H(5))(eta(2)-C(6)H(6))(+) (4a-e). The pi-benzene complexes 4a-c, sterically protected at Pt, eliminate benzene at ca. 0 degree C. The sterically less protected 4d-e lose benzene already at -30 degrees C. SST and 2D EXSY NMR demonstrate that phenyl and pi-benzene ligand protons undergo exchange with concomitant symmetrization of the diimine ligand, most likely via oxidative insertion of Pt into a C-H bond of coordinated benzene. The kinetics of the exchange processes for 4a-c were probed by quantitative EXSY spectroscopy, resulting in DeltaH() of 70-72 kJ mol(-1) and DeltaS of 37-48 J K(-1) mol(-1). A large, strongly temperature-dependent H/D kinetic isotope effect (9.7 at -34 degrees C; 6.9 at -19 degrees C) was measured for the dynamic behavior of 4a versus 4a-d(10), consistent with the proposed pi-benzene C-H bond cleavage. The fact that the pi-benzene complex 4a is thermally more robust in the absence of MeCN than is the Pt(IV) hydridodiphenyl complex 3a in the presence of MeCN agrees with the notion that arene elimination from Pt(IV) hydridoaryl complexes occurs via Pt(II) pi-arene intermediates that eliminate the hydrocarbon associatively, in this case, promoted by MeCN. Compounds 1a, 1b, 1d, 2a, and 2b have been crystallographically characterized.
A detailed kinetic study of the protonation and subsequent reductive elimination reaction of a (diimine)platinum(II) dimethyl complex was undertaken in dichloromethane over the temperature range of -90 to +10 degrees C by stopped-flow techniques. Time-resolved UV-vis monitoring of the reaction allowed the assessment of the effects of acid concentration, coordinating solvent (MeCN) concentration, temperature, and pressure. The second-order rate constant for the protonation step was determined to be 15200 +/- 400 M(-1) s(-1) at -78 degrees C, and the corresponding activation parameters are DeltaH = 15.2 +/- 0.6 kJ mol(-1) and DeltaS = -85 +/- 3 J mol(-1) K(-1), which are in agreement with the addition of a proton that results in the formation of the platinum(IV) hydrido complex. The kinetics of the second, methane-releasing reaction step do not show an acid dependence, and the MeCN concentration also does not significantly affect the reaction rate. The activation parameters for the second reaction step were found to be DeltaH = 75 +/- 1 kJ mol(-1), DeltaS = +38 +/- 5 J mol(-1) K(-1), and DeltaV = +18 +/- 1 cm(3) mol(-1), strongly suggesting a dissociative character of the rate-determining step for the reductive elimination reaction. The spectroscopic and kinetic observations were correlated with NMR data and assisted the elucidation of the underlying reaction mechanism.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.